Rigen Biotech
Latest round
- Series B
Last raised
- May 2025
Total raised
- $45M
Investors
- 8
About Rigen Biotech
, doing business as Rigen Biotech, is a high-technology company that focuses on the development, production, sales and testing services of individual molecular diagnosis products. The company has an international standard GMP plant and R&D laboratory covering an area of 2,500 square meters and has established a sound ISO13485 quality management system. In addition, the company has 7 domestic invention patents and 15 software copyrights. The company established a QPCR R&D laboratory in December 2017 and an NGS R&D laboratory in January 2018. Rigen Biotech received a Class I medical device product filing and a Class I medical device manufacturing filing in 2019. Rigen Biotech provides three main lines of products, including medical consumables such as disposable thyroid biopsy needle products which are specifically designed for obtaining thyroid tissue specimens via percutaneous puncture; PCR (polymerase chain reaction) testing platforms such as real-time quantitative PCR and digital PCR testing devices which are used in fields such as pathogen determination, tumor gene detection and polymorphism research; and NGS (next-generation sequencing) DNA sequencing platforms which are applied in de novo sequencing assembly, transcriptome sequencing and methylation detection, etc. The company generates revenue from developing and sales of medical consumables and testing devices for thyroid disease and oncology sectors.
Who invested in Rigen Biotech
8 investors across 3 rounds
See all investors in Rigen Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rigen Biotech
Who invested in Rigen Biotech?
Rigen Biotech has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rigen Biotech raised?
Rigen Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Rigen Biotech last raise money?
Rigen Biotech's most recent round on record is a Series B, in May 2025.
What does Rigen Biotech do?
, doing business as Rigen Biotech, is a high-technology company that focuses on the development, production, sales and testing services of individual molecular diagnosis products.
Where is Rigen Biotech headquartered?
Rigen Biotech is headquartered in Shanghai, China.
Which VCs invest in companies like Rigen Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Rigen Biotech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Rigen Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.